HAYWARD, Calif. (July 22, 2003) – IMPAX Laboratories Inc. (Nasdaq NM: IPXL)
today announced that the Company will release 2003 second quarter financial results
on Monday, July 28, 2003.
Barry R. Edwards, Co-Chief Executive Officer, and Cornel C. Spiegler, Chief
Financial Officer, will host an investment conference call beginning at 8:30
a.m. Eastern Time (5:30 a.m. Pacific Time) on July 28, 2003 to discuss these
results and to answer questions.
To participate in the live call by telephone, please dial (888) 803-7396 from
the U.S., or for international callers, please dial (706) 634-1052.
Those interested in listening to the conference call live via the Internet
may do so by visiting the Company's web site at www.impaxlabs.com. To listen
to the live call, please go to the Web site 15 minutes prior to its start to
register, download, and install the necessary audio software.
A replay will be available on the Company web site for 14 days beginning July
28, 2003. A telephone replay will be available from 9:30 a.m. Eastern Time July
28, 2003 through 11:59 p.m. Eastern Time July 30, 2003 by dialing (800) 642-1687
from the U.S., or (706) 645-9291 for international callers, and entering reservation
1824737.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company
applying its formulation expertise and drug delivery technology to the development
of controlled-release and specialty generics in addition to the development
of branded products. IMPAX markets its generic products through its Global Pharmaceuticals
division and intends to market its branded products through the IMPAX Pharmaceuticals
division. Additionally, where strategically appropriate, IMPAX has developed
marketing partnerships to fully leverage its technology platform. IMPAX Laboratories
is headquartered in Hayward, California, and has a full range of capabilities
in its Hayward and Philadelphia facilities. For more information, please visit
the Company's Web site at: www.impaxlabs.com.